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ABSTRACT
The ﬁrst methicillin-resistant Staphylococcus aureus (MRSA) strain originated when a staphylococcal
cassette chromosome mec (SCCmec) with the gene mecA was integrated into the chromosome of a
susceptible S. aureus cell. The SCCmec elements are common among the coagulase-negative staphylo-
cocci, e.g. Staphylococcus haemolyticus, and these are considered to be potential SCCmec donors when new
clones of MRSA arise. An outbreak of MRSA occurred at a neonatal intensive-care unit, and the isolates
were all of sequence type (ST) 45, as characterized by multilocus sequence typing, but were not typeable
with respect to SCCmec types I, II, III or IV. During the same time period, methicillin-resistant
S. haemolyticus (MRSH) isolates identiﬁed in blood cultures at the same ward were found to be
genotypically homogenous by pulsed-ﬁeld gel electrophoresis, and did not carry a type I, II, III or IV
SCCmec either. Thus, the hypothesis was raised that an SCCmec of MRSH had been transferred to a
methicillin-susceptible S. aureus strain and thereby created a new clone of MRSA that caused the
outbreak. This study showed that MRSA from the outbreak carried a ccrC and a class C mec complex that
was also found among MRSH isolates. Partial sequencing of the mec complexes showed more than 99%
homology, indicative of a common type V SCCmec. This ﬁnding may provide evidence for a recent
horizontal transfer of an SCCmec from MRSH to an identiﬁed potential recipient, an ST45 methicillin-
susceptible S. aureus strain, thereby creating a new clone of MRSA that caused the outbreak.
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INTRODUCTION
The ﬁrst methicillin-resistant Staphylococcus aureus
(MRSA) strain arose when a staphylococcal cas-
sette chromosome mec (SCCmec) with the gene
mecA was integrated into the chromosome of a
susceptible S. aureus strain [1]. Although very few
MRSA clones have disseminated internationally
[2–4], it is clear that new clones are continuously
arising, spreading and adapting to environments
predominantly outside the hospital settings [5,6].
The community-acquired MRSA (CA-MRSA)
clones seem to have much more diverse origins
than the nosocomial strains, and it is believed that
these new clones of MRSA arise spontaneously
and independently outside the hospital environ-
ment [7]. However, an interesting recent ﬁnding
is that not only the CA-MRSA but also the
hospital-acquired MRSA isolates in a low-ende-
mic area, such as O¨rebro County, Sweden, repre-
sent a large variety of clones [8]. This clearly
illustrates that the MRSA isolates studied here
consist mainly of sporadic and imported cases,
and that no clonal spread has taken place in the
O¨rebro University Hospital (O¨UH).
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A possible reservoir and donor of resistance
genes is the large group of coagulase-negative
staphylococci (CoNS) that are known to carry
SCCmec elements at a high frequency. Staphylo-
coccus haemolyticus is well known for its multidrug
resistance. It is considered to be one of the most
virulent CoNS, and sequencing has been per-
formed in order to characterize and understand
this species in detail [9].
So far, six structurally different types of
SCCmec (I, II, III, IV, V and VI) have been
identiﬁed in MRSA, and these contain a charac-
teristic combination of two essential genetic com-
ponents, the mec gene complex (class A, B or C)
and the cassette chromosome recombinase (ccr)
gene complex (type 1, 2, 3, 4 or 5) [1,10–12]. The
SCCmec types IV and V have been associated with
the emerging MRSA strains that are disseminat-
ing in the community and, in addition, several
unknown types of SCCmec have been found
among the CA-MRSA isolates [13,14]. Essential
for transfer of an SCCmec element between two
bacterial species is the action of the cassette
chromosome recombinases, which are capable of
excising and integrating the element into the
bacterial chromosome at a speciﬁc site located at
the 3¢-end of the open reading frame X (orfX) [15].
It is likely that a smaller size of SCCmec, as in the
case of type IV and type V, may provide an
advantage when the element is transferred among
bacteria, thereby creating new clones of MRSA.
An outbreak of MRSA occurred at the neonatal
intensive-care unit (NICU) at O¨UH in 1998, and
these isolates were all sequence type (ST) 45, as
determined by multilocus sequence typing
(MLST), but were not typeable with respect to
SCCmec types I, II, III or IV [8,16]. During the
same period, methicillin-resistant S. haemolyticus
(MRSH) isolates identiﬁed in blood cultures
obtained from patients at the same NICU were
found to be genotypically homogenous as deter-
mined by pulsed-ﬁeld gel electrophoresis (PFGE)
[17] and did not carry type I, II, III or IV SCCmec
elements either. Thus, the hypothesis was raised
that an endemic MRSH strain (or strains) has
transferred an SCCmec element to a methicillin-
susceptible S. aureus (MSSA) strain and thereby
created a new clone of MRSA that caused the
present outbreak in the NICU.
The aimof this studywas to examine the SCCmec
elements of theMRSA and theMRSH isolates from
the NICU, to investigate the homology among
them, and to compare isolateswith other origins, in
order to evaluate possible horizontal acquisition of
an SCCmec element.
MATERIALS AND METHODS
Bacterial isolates
The material analysed consisted of all MRSA (n = 35) and
MRSH (n = 16) isolates from O¨rebro County that did not
carry SCCmec type I, II, III or IV elements. Twenty-ﬁve of the
MRSA isolates had a direct or indirect association with an
outbreak in the NICU at O¨UH in 1998. Of the remaining
isolates, nine were regarded as CA-MRSA and one as
hospital-acquired MRSA with a possible origin in China [8].
All MRSH isolates were from the hospital setting, and all but
one isolate originated from the NICU [17]. The exception was
an MRSH isolate from a patient at the general intensive-care
unit at O¨UH. All MRSH isolates were cultured from blood.
Also, all MSSA isolates detected in blood cultures at the
NICU from 1990 to 1998 were screened. Those with the same
toxin proﬁle, determined by SET-RPLA (reverse passive latex
agglutination), TST-RPLA and EXT-RPLA (Denka Seiken,
Tokyo, Japan), similar to the MRSA isolated from the NICU,
i.e. negative for staphylococcal enterotoxins A, B, C, D and
toxic shock syndrome toxin-1, as well as exfoliative toxins A
and B, were selected (n = 28). The 15 MRSH isolates from the
NICU were previously investigated genotypically by PFGE
and phenotypically by the Phene Plate system, and consti-
tuted one major clone and one additional single isolate [17].
The MRSH isolate from the general intensive-care unit had a
unique PFGE pattern in comparison with the major clone of
MRSH originating from the NICU (unpublished data), but
was possibly related to the additional single isolate identiﬁed
at the NICU.
S. aureus isolates were identiﬁed by routine diagnostic
procedures, including DNase and coagulase tests. The species
S. haemolyticus was determined by using the ID32 Staph
system (BioMe´rieux, Marcy l’Etoile, France). Antibiotic sus-
ceptibility testing was performed using disk diffusion and the
Etest (AB Biodisk, Solna, Sweden), as recommended by the
Swedish Reference Group for Antibiotics (SRGA) and the
SRGA subcommittee on methodology (http://www.srga.org).
The following antibiotics were tested: oxacillin–cefoxitin,
fusidic acid, clindamycin, ciproﬂoxacin, erythromycin, genta-
micin, rifampin and vancomycin. Resistance to oxacillin (MIC
>1.0 mg ⁄L according to the SRGA guidelines) was measured
using the Etest. Methicillin resistance was conﬁrmed by
detecting the presence of mecA. The nuc gene, which is speciﬁc
for S. aureus, was detected to verify MRSA [16].
DNA isolation and preparation
All isolates were cultured on blood agar (Columbia II agar
(BD Diagnostic Systems, Sparks, MD, USA)) 4.25% w ⁄v and
deﬁbrinated horse blood (SVA, Uppsala, Sweden) 6% (w ⁄v)
and incubated overnight at 37C. The S. haemolyticus isolates
were prelysed with lysozyme (25 mg ⁄mL) and lysostaphin
(2 mg ⁄mL) (Bio-Rad Laboratories AB, Sundbyberg, Sweden)
before automated DNA isolation from all isolates using
the MagNa Pure LC DNA Isolation Kit III and the MagNa
Pure LC Instrument (Roche Diagnostics, Mannheim,
Germany).
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Spa typing
Spa typing of the MSSA and MRSA isolates originating from
the NICU was performed according to Harmsen et al. [18], and
adapted to the LightCycler System PCR with the SYBR Green I
dye. Samples contained 0.5 lM forward primer, 0.3 lM
reverse primer, and 3 mM MgCl2, and were pre-incubated
for 10 min at 95C and then subjected to 35 cycles of
ampliﬁcation according to the following schedule: denatur-
ation by bringing to 95C and immediately annealing at 55C
for 5 s, and extension at 72C for 18 s.
Melting curve analysis was conducted by continuously
registering the ﬂuorescence while slowly raising the temper-
ature (0.1C ⁄ s) from 65C to 95C. Prior to sequencing, the
products were puriﬁed using the MultiScreen PCRl96 Plate
(Millipore AB, Solna, Sweden); both strands were sequenced
using the PCR primers and the ABI PRISM BigDye Terminator
version 3.1 Ready Reaction Cycle Sequencing Kit (Applied
Biosystems, Stockholm, Sweden) and separation on an ABI
PRISM 3100 Genetic Analyzer (Applied Biosystems).
Spa types were determined with the Ridom StaphType
software (Ridom GmbH, Wu¨rzburg, Germany) and grouped
using the BURP (based upon repeat pattern) algorithm.
MLST
MLST of MRSA and MSSA with different spa types was
performed using primer sequences developed by Enright et al.
[19] and Crisostomo et al. [3], using the real-time LightCycler
System PCR ampliﬁcation of the seven housekeeping genes in
the same PCR program [8]. The STs were grouped into clonal
complexes that shared a common ancestor as predicted by the
BURST (based upon related sequence types) software.
Determination of SCCmec types
The SCCmec typing was performed using the real-time Light-
Cycler System PCR to detect the essential genetic components
mecA,mecR1, IS1272, ccrA and ccrB, according to Berglund et al.
[16]. ccrC (type 5 ccr) was detected as previously described
[12], using the LightCycler System PCR with the SYBR Green I
dye. Samples contained 0.3 lM of each primer and 3 mM
MgCl2, and were pre-incubated for 10 min at 95C and then
subjected to 40 cycles of ampliﬁcation according to the
following schedule: denaturation at 95C for 10 s, annealing
at 57C for 5 s, and extension at 72C for 21 s.
Melting curve analysis was conducted by continuously
registering the ﬂuorescence while slowly raising the temper-
ature (0.1C ⁄ s) from 65C to 95C.
Detection of the class C mec complex was done by using
the primers IS2 and mA2 [20] and ampliﬁcation with a
long-range PCR on a GeneAmp PCR System 9700 (Applied
Biosystems). This protocol uses two-temperature cycling (94C
for 15 s; 68C for 10 min) and involves a 15-s automatic
segment extension for the annealing ⁄ extension step in the last
12 cycles.
Partial sequencing of the class C mec complex
The class C mec complex was further investigated in a selection
of 12 isolates, chosen in order to obtain as many different
genotypes as possible according to pulsotype, MIC of oxacillin,
resistance markers and other dissimilar characteristics. Two
isolates were MRSA (98B249 and 98PP038) and originated
from the outbreak but had a one-band difference in the PFGE
pattern. Ten of the isolates were MRSH and were selected
according to the criteria above.
The partial DNA sequence of the class C mec gene com-
plexes was determined by amplifying the complex and its
ﬂanking regions and subsequent cyclic sequencing of the 4-kb
product with several sets of primers that overlap the sequences
on both strands. To cover the region of interest (mecA–DmecR1–
IS431), two additional PCRs were run to cover the ﬂanking
regions of mecA and IS431. Primers AFW (5¢-AGCGGG
TTATGAATTGAACG-3¢) and AR (5¢-CCACCCTCAAA
CAGGTGAAT-3¢) anneal at the end of mecA and immediately
upstream of the gene, and allowed production of a 1652-bp
product. Primers IFW (5¢-AAATGGCGTATTGATGAGACG-3¢)
and IR (5¢-CACTCAAAATGCAGAGGGTTT-3¢) were used to
amplify the end of IS431 and its right-side ﬂanking region.
Because of different features in this area that were revealed by
subsequent sequencing, primers HaeFW (5¢-TCGGACGTT
CAGTCATTTCT-3¢) and HaeR (5¢-GTGTTACGCGCACACCT
AGA-3¢) were synthesized and used for the same purpose in
isolates that were impossible to amplify using the IFW ⁄ IR
primers.
The PCR products were puriﬁed using the High Pure PCR
Puriﬁcation Kit (Roche Diagnostics) and subsequently
sequenced using the ABI PRISM BigDye Terminator ver-
sion 3.1 Ready Reaction Cycle Sequencing Kit (Applied Bio-
systems). The puriﬁed sequencing reactions were subse-
quently separated on an ABI PRISM 3100 Genetic Analyzer
(Applied Biosystems).
The nucleotide sequences were analysed using ABI PRISM
AutoAssembler DNA Sequence Assembly 1.4.0 software
(Applied Biosystems) and BioEdit Sequence Alignment Editor
v.7.0.1 (Isis Pharmaceuticals Inc, CA, USA), and were com-
pared with sequences in the databases at the National Center
for Biotechnology Information (NCBI) with the basic local
alignment search tool BLAST (Bethesda, MD, USA: National
Library of Medicine (http://www.ncbi.nlm.nih.gov)). The
phylogenetic comparison was done using the ClustalW align-
ment program and Treecon v.1.3b (University of Konstanz,
Germany).
Long-range PCR in SCCmec
To investigate whether the ccrC-carrying MRSH isolates had
the same SCCmec element as the MRSA isolates, two long-
range PCRs were performed using the Expand High Fidelity
PCR System (Roche Diagnostics) at a ﬁnal volume of 50 lL.
The PCR reaction consisted of an initial denaturation (94C,
2 min), 10 cycles of denaturation (94C, 15 s), annealing (50C,
30 s), and extension (68C, 8 min), followed by 20 cycles of
denaturation (94C, 15 s), annealing (50C, 30 s), and extension
(68C, 12 min), and a ﬁnal prolonged elongation (72C, 7 min).
The ﬁrst PCR was performed using only primer IS2 to amplify
the region between the two IS431 elements located on either
side of mecA in opposite directions. To conﬁrm the presence of
mecA inside the PCR product ﬂanked by the IS431 copies, a
second PCR was performed using the ﬁrst PCR product as
template.
The second long-range PCR covered ccrC and mecA,
employing primers mAU (5¢-GCAATCGCTAAAGAAC
TAAG-3¢) and cF (5¢-CCTTTATAGACTGGATTATTCAAAA
TAT-3¢) [12], and was performed under the same conditions as
described above.
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Nucleotide sequence accession numbers
The nucleotide sequences of the partial class C mec complex of
theMRSH andMRSA isolates representing group 2 (see below)
have been deposited in the DDBJ ⁄EMBL ⁄GenBank under
accession numbers AB437289 and AB437290, respectively.
RESULTS
Epidemiology of the MSSA and MRSA isolates
from the NICU
The MSSA isolates were investigated in an
attempt to identify the possible recipient clone
that became MRSA after integration of an
SCCmec element. Spa typing of the selected 28
clinical MSSA isolates obtained from blood
cultures was performed in order to further
investigate the clonality of the isolates collected
at the NICU during the period 1990–1998. The
isolates were of 15 different spa types (t012, t015,
t045, t065, t084, t085, t104, t122, t246, t279, t298,
t491, t706, t1374 and t2722), which were grouped
into three major clusters and ﬁve singletons
using the BURP algorithm. Interestingly, two
isolates were impossible to spa type, due to
unsuccessful ampliﬁcation, and may have alter-
ations in, or lack, the spa gene. There was a clear
dominance of one clone of MSSA according to
spa type (t084, t085, t279, t491), comprising 14
isolates, during the period 1990–1995, which was
thereafter replaced by a second clone (t015, t065,
t706) comprising four isolates present during the
period 1994–1998. The third clone (t012, t122,
t298), comprising three isolates, and the remain-
ing ﬁve isolates were of spa types t045, t104, t246,
t1374 and t2722 and were not related to any of
the other isolates.
In contrast, the 35 MRSA isolates that did not
carry SCCmec type I, II, III or IV elements were
assigned to nine different spa types (t015, t127,
t186, t355, t630, t667, t1028, t1154, t1156), and all of
the 25 isolates that originated from the outbreak at
the NICU were t015, except for one isolate of the
closely related spa type t630.
Further MLST analysis allowed grouping of the
isolates of the ﬁrst spa clone (t084, t085, t279, t491)
of MSSA as ST15 or the single-locus variant ST16,
whereas the second spa clone (t015, t065, t706), as
well as the spa-negative isolates, were ST45 or
single-locus variant ST46. The MRSA isolates
from the NICU were all previously assigned to
ST45.
Susceptibility proﬁles
Thirty-four of 35 MRSA isolates had low-level
resistance (MIC: 1–4 mg ⁄L) to oxacillin, except for
the MRSA isolate originating from China
(>256 mg ⁄L), whereas for 13 of the MRSH iso-
lates, an MIC >256 mg ⁄L was determined, for
two an MIC of 32 mg ⁄L, and for one an MIC of
1 mg ⁄L. All MRSA and MRSH isolates originat-
ing from the NICU and two additional MRSA
isolates were resistant to gentamicin. In addition,
two MRSH isolates were resistant to fusidic acid.
SCCmec typing of the MRSH isolates
The MRSH isolates were not categorized as type I,
II, III or IV SCCmec using the same nomenclature
as for MRSA, because of a more complex organi-
zation of SCCmec in multiresistant CoNS. The
SCCmec typing was performed only with the
purpose of ﬁnding similarities and differences as
compared with the elements in MRSA. All 16
MRSH isolates carried the class C mec complex,
and one isolate had a class A mec complex as well.
Also, all 16 MRSH isolates carried IS1272 some-
where in the chromosome, but the insertion did
not disrupt mecR1, as is the case with the class B
mec complex.
Two isolates carried ccrC (type 5 ccr) and one
isolate had the type 2 ccr genes. The other 13
isolates were either lacking ccr genes or carried
novel types.
SCCmec typing of MRSA isolates
The 35 MRSA isolates have previously been
characterized as not carrying type I, II, III or IV
SCCmec [16], and were further investigated
regarding type V SCCmec and the presence of
ccrC and the class C mec complex. Thirty-one of
these isolates, including all those originating from
the NICU, had the class C mec complex and ccrC,
and were of SCCmec type V. The isolates com-
prised spa types t015, t127, t186, t355, t630 and
t1156, of which t015, t630 and t1156 were closely
related and represented ST45.
Sequencing of the class C mec complex
The DNA sequence of the class C mec gene
complexes was determined in 12 isolates repre-
senting both MRSA and MRSH by amplifying the
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mec complex and its ﬂanking regions using long-
range PCR and subsequent cyclic sequencing of
the 4-kb product with several sets of primers that
overlap the sequences on both strands. Detailed
characteristics of the selected isolates are pre-
sented in Table 1. Five different sequence variants
were identiﬁed when the structures of the class C
mec gene complex were investigated, and those
could be clustered into two major groups using
the ClustalW alignment program. The ﬁrst group
(group 1) was represented by MRSH only (n = 8)
and was 100% identical to the class C mec
complex of the MRSH isolate JCSC1435 (accession
no. AP006716) [9]. The MRSH isolates in this
group dated from 1991 to 1997, and were well
conserved, as no internal mutations were seen
among the sequences. The second group
(group 2) consisted of both MRSA (n = 2) and
MRSH (n = 2), and showed more than 99%
homology to the class C2 mec complex previously
described in the type VT SCCmec of isolate
TSGH17 (accession no. AY894415) [21] and isolate
JCSC3624 (WIS) (accession no. AB121219) [12].
The phylogenetic relationship among the class C
mec sequences is presented in Fig. 1, and a
schematic illustration is shown in Fig. 2. The
two MRSA isolates in group 2 were ST45, and
originated from the NICU, whereas the MRSH
isolates in group 2 consisted of one isolate orig-
inating from the NICU and another from the
general intensive-care unit, with no obvious
connection to the NICU. The MRSA and MRSH
isolates in group 2 were genetically closely
related, and only ﬁve substitutions in the class C
mec sequences were identiﬁed. The mecA and the
mecR1 genes were conserved among all investi-
gated isolates. The major difference between
groups 1 and 2 was seen in the IS431 element
located downstream from mecR1, where 12 of the
mutations were non-synonymous and gave rise to
amino acid changes. Interestingly, three of the
codon changes resulted in premature stop codons
(amino acid positions 48, 50 and 134) in group 2.
No homology was seen between groups 1 and 2
downstream from IS431.
A CcrC-driven SCCmec
To further support the assumption that the
investigated ccrC-carrying MRSH isolates
(91B250 and 92B030) had the same SCCmec as
MRSA isolates 98B249 and 98PP038, two long-
range PCRs were performed for the two MRSH
isolates, one of the MRSA isolates (98B249), and
the MRSH isolate with the different (group 1) mec
complex (97B641). The ﬁrst PCR covered the two
IS431 elements on either side of mecA, and
successfully ampliﬁed an approximately 6-kb
fragment in isolate 98B249 (MRSA) as well as in
isolates 91B250 and 92B030 (MRSH), all belonging
to group 2. No band was seen in isolate 97B641
(MRSH) from group 1. A nested PCR was suc-
cessfully performed to conﬁrm the presence of the
mecA gene in the PCR product, using the product
as template. The second long-range PCR was
performed to cover ccrC and mecA, and a similar
band of c. 5.5 kb was seen in isolate 98B249
(MRSA) as well as in isolates 92B030 and 91B250
(MRSH) from group 2. The distance between the
PCR primer positions in ccrC and mecA would
have been approximately 9 kb for the type V
SCCmec described in strain WIS. No ccrC was
Table 1. Characteristics of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus
haemolyticus (MRSH) isolates with a class C mec complex that were further investigated by nucleotide sequencing
Isolate Year of isolation
Staphylococcal
group
ccr type mec class
IS1272 PVL Source
MIC of
OXA (mg ⁄L) Resistance1 2 3 C A B C
90B-647 1990 MRSH – – – – – – + + – Blood >256 GEN
91B-250 1991 MRSH – – – + – – + + – Blood 32 GEN
91B-345 1991 MRSH – – – – + – + + – Blood >256 GEN
91B-591 1991 MRSH – – – – – – + + – Blood 1 GEN
92B-030 1992 MRSH – – – + – – + + – Blood 32 GEN
95B-229 1995 MRSH – – – – – – + + – Blood >256 GEN
96B-036 1996 MRSH – + – – – – + + – Blood >256 GEN, CIP, FUS
96B-395 1996 MRSH – – – – – – + + – Blood >256 GEN
97B-321 1997 MRSH – – – – – – + + – Blood >256 GEN
97B-641 1997 MRSH – – – – – – + + – Blood >256 GEN, CIP
98B-249 1998 MRSA – – – + – – + – – Blood 2 GEN, CIP
98PP-038 1998 MRSA – – – + – – + – – Skin 2 GEN, CIP
OXA, oxacillin; GEN, gentamicin; FUS, fusidic acid; CIP, ciproﬂoxacin; PVL, Panton–Valentine leukocidin; ), negative; +, positive.
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identiﬁed in the isolates of group 1. These results
conﬁrm that ccrC was located in close proximity
to mecA, and that it was probably part of SCCmec.
Sequencing of a 696-bp region of ccrC of isolate
98B249 revealed the closest similarity (97%) with
ccrC7, previously described in Staphylococcus epi-
dermidis strain 13-48 [22], whereas it was only
90% similar to ccrC described in isolates WIS and
JCSC1435.
DISCUSSION
The hypothesis of this study was that an SCCmec
element had been transferred from an MRSH into
anMSSA isolate, resulting in a new clone of MRSA
that caused an outbreak in the NICU at O¨UH,
located in a low-endemic area in Sweden in 1998.
The initial indication was a temporal association
between a resident clone of MRSH from the NICU
Fig. 1. Five sequence variants identiﬁed when investigating the structures of the class C mec gene complex of MRSA and
MRSH, clustered into two major groups using ClustalW alignment. The ﬁrst group (group 1) was represented by MRSH
only (n = 8) and contained a class C mec complex 100% identical to that of the MRSH isolate JCSC1435. The second group
(group 2) was represented by both MRSA (n = 2) and MRSH (n = 2), showing 99% homology to the class C2 mec complex
previously described in the type VT SCCmec of isolates TSGH17 and JCSC3624 (WIS). The letter H in front of the isolate
name indicates MRSH, and the letter A indicates MRSA.
TSGH17 IS431
IS431JCSC1435
JCSC3624 (WIS)
Group 1 
Group 2 
IS431
mecA
mecA
mecA
mecA
mecA mecR1
mecR1
mecR1
mecR1
mecR1 IS431
IS431
IS431
IS431
IS431
class C2 mec
AFW AR
mA2 IS2
HaeFW HaeR
IFW IR
Fig. 2. Schematic illustration of the
class C mec complex identiﬁed in
this study and comparison with
extant mec complexes. The struc-
tures of the extant mec complexes
are illustrated on the basis of the
nucleotide sequence deposited in
the DDBJ ⁄EMBL ⁄Genbank database
under accession numbers AP006716,
AY894415 and AB121219. The
position and direction of the PCR
primers are indicated by black
arrowheads, and demarcate the
subsequently sequenced regions.
Conserved regions are indicated in
brown (100% homology) and beige
(97–99% homology).
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[17] prior to the outbreak, and the fact that both the
MRSA isolates [16] and the MRSH isolates were
untypeablewith respect to SCCmec types I, II, III or
IV. The aim of the studywas to identify the SCCmec
element of the MRSA and MRSH isolates, and to
further characterize the mec gene complexes by
partial nucleotide sequencing. The MRSA isolates
involved in the outbreak were assigned to type V
SCCmec, as a class C mec complex and a ccrC gene
were identiﬁed. Furthermore, the class C mec
complex was identiﬁed in all investigated MRSH
isolates, but only two of them carried ccrC, as did
the MRSA isolates The MRSH isolates originating
from the NICU have previously been investigated
by PFGE and the Phene Plate system, andmade up
one homogenous clone [17] that was considered to
be endemic in the NICU. In contrast, the ﬁnding of
different ccr and mec complexes in, as well as
different antibiotic susceptibility proﬁles of, this
endemic clone was an indication of promiscuous
behaviour or of a high rate of rearrangement
among these isolates. However, the MRSH clone
that had been present in the NICU for many years
disappeared andwas not detected again after 1998.
Further sequencing of the class C mec complex
in a selection of MRSA and MRSH isolates
revealed that they are clustered into two groups.
Interestingly, one of them included both theMRSA
and MRSH from the NICU. The class C mec
complexes identiﬁed in MRSA and MRSH isolates
from the NICU were 99% identical, which may
indicate recent transfer of a type V SCCmec ele-
ment. The recent horizontal acquisition of SCCmec
was driven by CcrC, whose gene was identiﬁed at
the same position in both MRSA and MRSH
isolates of the same group, and which showed
closest homology with ccrC7, previously described
in an S. epidermidis isolate (accession no EF190468).
This ﬁnding further supports the hypothesis of
recent horizontal transfer of an SCCmec complex
carrying ccrC and a class C mec complex between
MRSH and MSSA isolates in the NICU. We have
not further investigated the chromosomal site-
speciﬁc excision and integration of the type V
SCCmec element, although it has been stated that
the CcrC recombinase is functionally intact [1].
We considered that the SCCmec typing of MRSA
isolates could not be applied in the samemanner to
MRSH isolates, as they may harbour several
adjacent SCCmec elements [9]. The ﬁnding of
several ccr or mec complexes in the same isolate
indicated that this was also the case in some of the
MRSH isolates in the present study. In contrast,
many of the MRSH isolates were negative accord-
ing to PCR for ccr type 1, 2 and 3 and ccrC, although
it is possible that these isolates carry novel ccr
variants that are located inside or outside SCCmec.
It has recently been shown that insertion of
additional exogenous material may result in a loss
of recombinase function, thereby stabilizing
SCCmec in the chromosome [23].Also, the insertion
sequence IS1272, which is present in the class Bmec
complex of type I and IV SCCmec, was detected in
allMRSH isolates but not in any of the investigated
MRSA isolates. It is known, however, that several
copies of IS1272 exist in the S. haemolyticus genome
but not necessarily within SCCmec [24].
The most prevalent clone of MRSH that
belonged to group 1 exhibited a high level of
resistance to oxacillin (>256 mg ⁄L), which may
have been a survival advantage of the MRSH
strain present in a hospital environment, e.g. in
the NICU. In contrast, for all MRSA isolates
associated with the outbreak, as well as the MRSH
isolates constituting group 2, MICs of oxacillin of
1–32 mg ⁄L were determined. It is possible that
the rearrangement of the SCCmec complex and
the removal of the ccr genes that have occurred in
group 1 have stabilized SCCmec to better adapt
the MRSH strain for survival in a hospital
environment. This could be compared with the
inability of SCCmec elements to transfer that has
been observed with types I, II and III, which are
prevalent in nosocomial MRSA isolates [7].
The MRSA isolates causing the outbreak in the
NICUwere assigned to ST45byMLST [8], andST45
was also identiﬁed amongMSSA isolatespresent in
the NICU during the 1990s. Members of ST45 may
constitute the recipient clone of MSSA into which
SCCmec has been integrated, thereby creating the
MRSA clone with the type V SCCmec element that
caused the outbreak in the NICU. Since the out-
break in 1998, no additional MRSA isolates of
SCCmec type V and ST45 have been identiﬁed in
O¨rebroCounty. The reason for this is unknown, but
it may be due to implementation of hygiene
procedures and improved infection control prac-
tices, including repeated screening of cultures for
MRSA among patients and healthcare workers in
the NICU in an attempt to prevent further spread.
This may also be the reason for the disappearance
of the resident MRSH clone in the NICU. ST45
represents one of the predominant genetic
backgrounds of MRSA in Europe, whose members
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have been reported to carry different types of
SCCmec elements [25,26], which probably reﬂects
independent integration of these elements into this
successful clone. In addition,MRSA representative
of an epidemic MRSA, designated as the Berlin
clone (ST45, SCCmec type IV), caused a serious
outbreak in aNICU in Israel in 2003,which resulted
in the death of two children, but in contrast towhat
was observed in the present study, this MRSA
clone was identical to that previously identiﬁed in
the community [27].
The class C mec complex, ﬁrst described in
MRSA in Australia in 2002 [6], has also been
found in S. haemolyticus and S. epidermidis [20],
and was identiﬁed as a part of the type V SCCmec
[12]. Since then, type V SCCmec has been increas-
ingly found in MRSA isolates, especially CA-
MRSA isolates [21,28]. In contrast, the presence of
the class C mec complex has been considered to be
an advantage of MRSH isolates that are dissem-
inating in the hospital environment [20]. Obvi-
ously, it is not only the SCCmec but also the host
species and its individual characteristics that
determine whether the resistant bacteria are
successful in terms of surviving and spreading.
In conclusion, a type V SCCmec element was
identiﬁed in both MRSA and MRSH isolates
simultaneously isolated in the NICU at O¨UH,
and the present study may provide support for
the hypothesis of recent horizontal transfer of an
SCCmec element from an MRSH donor to an
MSSA recipient, thereby creating a new clone of
MRSA that caused the outbreak in 1998.
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